Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 270

1.

Interactive association of sleep duration and sleep quality with the prevalence of metabolic syndrome in adult Chinese males.

Lu K, Zhao Y, Chen J, Hu D, Xiao H.

Exp Ther Med. 2020 Feb;19(2):841-848. doi: 10.3892/etm.2019.8290. Epub 2019 Dec 5.

2.

Characteristics of Newly Diagnosed Type 2 Diabetes in Chinese Older Adults: A National Prospective Cohort Study.

Lv F, Cai X, Hu D, Pan C, Zhang D, Xu J, Ji L.

J Diabetes Res. 2019 Nov 15;2019:5631620. doi: 10.1155/2019/5631620. eCollection 2019.

3.

Rationale and design of the Henan ST elevation myocardial infarction (STEMI) registry: a regional STEMI project in predominantly rural central China.

Zhang Y, Wang S, Yang S, Yin S, Cheng Q, Li M, Qi D, Wang X, Zhu Z, Zhao L, Hu D, Gao C.

BMC Cardiovasc Disord. 2019 Nov 28;19(1):271. doi: 10.1186/s12872-019-1250-9.

4.

Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).

Sun Y, Zhu J, Ma C, Liu S, Yang Y, Hu D.

Cardiovasc Ther. 2019 Mar 21;2019:7372129. doi: 10.1155/2019/7372129. eCollection 2019.

5.

Corrigendum to "Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model" [Stem Cell Research 38 (2019) 101483 Page 1-8].

Wang Z, Wang L, Liu W, Hu D, Gao Y, Ge Q, Liu X, Li L, Wang Y, Wang S, Li C.

Stem Cell Res. 2019 Dec;41:101526. doi: 10.1016/j.scr.2019.101526. Epub 2019 Sep 25. No abstract available.

6.

How Far is between Cancer and Health?

Hu C, Tkebuchava T, Wu Q, Hu D.

Iran J Public Health. 2019 May;48(5):974-976. No abstract available.

7.

Nature of Cardiac Rehabilitation Around the Globe.

Supervia M, Turk-Adawi K, Lopez-Jimenez F, Pesah E, Ding R, Britto RR, Bjarnason-Wehrens B, Derman W, Abreu A, Babu AS, Santos CA, Jong SK, Cuenza L, Yeo TJ, Scantlebury D, Andersen K, Gonzalez G, Giga V, Vulic D, Vataman E, Cliff J, Kouidi E, Yagci I, Kim C, Benaim B, Estany ER, Fernandez R, Radi B, Gaita D, Simon A, Chen SY, Roxburgh B, Martin JC, Maskhulia L, Burdiat G, Salmon R, Lomelí H, Sadeghi M, Sovova E, Hautala A, Tamuleviciute-Prasciene E, Ambrosetti M, Neubeck L, Asher E, Kemps H, Eysymontt Z, Farsky S, Hayward J, Prescott E, Dawkes S, Santibanez C, Zeballos C, Pavy B, Kiessling A, Sarrafzadegan N, Baer C, Thomas R, Hu D, Grace SL.

EClinicalMedicine. 2019 Jul 4;13:46-56. doi: 10.1016/j.eclinm.2019.06.006. eCollection 2019 Aug.

8.

Cardiac Rehabilitation Availability and Density around the Globe.

Turk-Adawi K, Supervia M, Lopez-Jimenez F, Pesah E, Ding R, Britto RR, Bjarnason-Wehrens B, Derman W, Abreu A, Babu AS, Santos CA, Jong SK, Cuenza L, Yeo TJ, Scantlebury D, Andersen K, Gonzalez G, Giga V, Vulic D, Vataman E, Cliff J, Kouidi E, Yagci I, Kim C, Benaim B, Estany ER, Fernandez R, Radi B, Gaita D, Simon A, Chen SY, Roxburgh B, Martin JC, Maskhulia L, Burdiat G, Salmon R, Lomelí H, Sadeghi M, Sovova E, Hautala A, Tamuleviciute-Prasciene E, Ambrosetti M, Neubeck L, Asher E, Kemps H, Eysymontt Z, Farsky S, Hayward J, Prescott E, Dawkes S, Santibanez C, Zeballos C, Pavy B, Kiessling A, Sarrafzadegan N, Baer C, Thomas R, Hu D, Grace SL.

EClinicalMedicine. 2019 Jul 3;13:31-45. doi: 10.1016/j.eclinm.2019.06.007. eCollection 2019 Aug.

9.

Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.

Wang Z, Wang L, Liu W, Hu D, Gao Y, Ge Q, Liu X, Li L, Wang Y, Wang S, Li C.

Stem Cell Res. 2019 Jul;38:101483. doi: 10.1016/j.scr.2019.101483. Epub 2019 Jun 11. Erratum in: Stem Cell Res. 2019 Sep 25;:101526.

10.

Evaluation of effectiveness of treatment paradigm for newly diagnosed type 2 diabetes patients in Chin: A nationwide prospective cohort study.

Cai X, Hu D, Pan C, Li G, Lu J, Ji Q, Su B, Tian H, Qu S, Weng J, Zhang D, Xu J, Ji L.

J Diabetes Investig. 2020 Jan;11(1):151-161. doi: 10.1111/jdi.13092. Epub 2019 Jul 2.

11.

The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study.

Cai X, Hu D, Pan C, Li G, Lu J, Ji Q, Su B, Tian H, Qu S, Weng J, Zhang D, Xu J, Ji L.

Sci Rep. 2019 May 22;9(1):7709. doi: 10.1038/s41598-019-44169-4.

12.

Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China: A Randomized Clinical Trial.

Wu Y, Li S, Patel A, Li X, Du X, Wu T, Zhao Y, Feng L, Billot L, Peterson ED, Woodward M, Kong L, Huo Y, Hu D, Chalkidou K, Gao R; CPACS-3 Investigators.

JAMA Cardiol. 2019 May 1;4(5):418-427. doi: 10.1001/jamacardio.2019.0897.

13.

Managing acute myocardial infarction in China.

Hu C, Tkebuchava T, Hu D.

Eur Heart J. 2019 Apr 14;40(15):1179-1181. doi: 10.1093/eurheartj/ehz182. No abstract available.

PMID:
30982072
14.

Screening for depression in acute coronary syndrome patients: A comparison of Patient Health Questionnaire-9 versus Hospital Anxiety and Depression Scale-Depression.

Yuan J, Ding R, Wang L, Sheng L, Li J, Hu D.

J Psychosom Res. 2019 Jun;121:24-28. doi: 10.1016/j.jpsychores.2019.03.018. Epub 2019 Mar 19.

PMID:
30928210
15.

Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.

Yan X, Li Y, Dong Y, Wu Y, Li J, Bian R, Hu D.

Lipids Health Dis. 2019 Jan 29;18(1):32. doi: 10.1186/s12944-019-0974-y.

16.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

Sawhney JP, Kothiwale VA, Bisne V, Durgaprasad R, Jadhav P, Chopda M, Vanajakshamma V, Meena R, Vijayaraghavan G, Chawla K, Allu J, Pieper KS, John Camm A, Kakkar AK; GARFIELD-AF Investigators.

Indian Heart J. 2018 Nov - Dec;70(6):828-835. doi: 10.1016/j.ihj.2018.09.001. Epub 2018 Sep 12.

17.

Prescription of statins at discharge and 1-year risk of major clinical outcomes among acute coronary syndromes patients with extremely low LDL-cholesterol in clinical pathways for acute coronary syndromes studies.

Sun Y, Xie G, Patel A, Li S, Zhao W, Yang X, Wu T, Li M, Li X, Du X, Hu R, Huo Y, Hu D, Gao RL, Wu Y.

Clin Cardiol. 2018 Sep;41(9):1192-1200. doi: 10.1002/clc.23040. Epub 2018 Sep 22.

18.

Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants.

Theodorakis MJ, Coleman RL, Feng H, Chan J, Chiasson JL, Ge J, Gerstein HC, Huo Y, Lang Z, McMurray JJ, Rydén L, Schröder S, Tendera M, Tuomilehto J, Yang W, Hu D, Pan C, Holman RR; ACE Study Group.

Am Heart J. 2018 May;199:170-175. doi: 10.1016/j.ahj.2017.09.001. Epub 2017 Sep 8. No abstract available.

PMID:
29754657
19.

Efficacy and effectiveness of valsartan/amlodipine and valsartan/amlodipine/hydrochlorothiazide in hypertension: randomized controlled versus observational studies.

Sison J, Vega RMR, Dayi H, Bader G, Brunel P.

Curr Med Res Opin. 2018 Mar;34(3):501-515. doi: 10.1080/03007995.2017.1412682. Epub 2018 Jan 22. Review.

PMID:
29210288
20.

Prevalence, treatment patterns and control rates of metabolic syndrome in a Chinese diabetic population: China Cardiometabolic Registries 3B study.

Jing Y, Hong T, Bi Y, Hu D, Chen G, Li J, Zhang Y, Zhang R, Ji L, Zhu D.

J Diabetes Investig. 2018 Jul;9(4):789-798. doi: 10.1111/jdi.12785. Epub 2018 Jan 12.

Supplemental Content

Loading ...
Support Center